Neuroprotection strategies: Effect of vinpocetinein in vitro oxidative stress models;Estratégias de neuroprotecção: Efeito da vimpocetina em modelos in vitro de stresse oxidativo

Acta Medica Portuguesa

Volumn 16, Issue 6, 2003, Pages 401-406

  Pereira, Cláudia ^a   Agostinho, Paula ^a   Moreira, Paula I ^a   Duarte, Ana I ^a   Santos, Maria S ^a   Oliveira, Catarina R ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Alzheimer's disease; Beta amyloid; Oxidative stress; Vinpocetine; Words

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; ASCORBIC ACID; IRON; NEUROPROTECTIVE AGENT; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE; SYNTHETIC PEPTIDE; VINCAMINE; VINPOCETINE;

ALZHEIMER DISEASE; ARTICLE; CELL PROTECTION; CLINICAL OBSERVATION; CLINICAL RESEARCH; DEGENERATIVE DISEASE; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; IN VITRO STUDY; NERVE CELL LESION; NEUROPROTECTION; OXIDATIVE STRESS; PATHOLOGICAL ANATOMY;

AMYLOID BETA-PROTEIN; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; VINCA ALKALOIDS;

EID: 9644310235     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. nd edn. Oxford University Press, Oxford
2. GUTTERIDGE JM: Hydroxyl radicals, iron, oxidative stresse, and neurodegeneration. Ann N Y Acad Sci 1994; 738: 201-213
3. CLEMENS JA, PANETTA JA: Neuroprotection by antioxidants in models of global and focal ischemia. Ann N Y Acad Sci 1994; 738: 250-256
4. EBADI M, SRINIVASAN SK, BAXI MD: Qxidative stresse and antioxidant therapy in Parkinson's disease. Prog Neurobiol 1996; 48: 1-19
5. ROBBERECHT W, BOSH LVD: The pathogenesis of amyotrophic lateral sclerosis. Neurosci Res Commun 1998; 23: 67-75
6. HARMAN D, EDDY DE, NOFFSINGER J: Free radical theory of aging: inhibition of amyloidosis in mice by antioxidants; possible mechanism. J Am Geriatr Soc 1976; 24: 203-210
7. HARMAN D: Free radical theory of aging: Alzheimer's disease pathogenesis. Age 1995; 18: 97-119
8. SELKOE DJ: The molecular pathology of Alzheimer's disease. Neuron 1993; 6: 487-498
9. BEHL C, DAVIS JB, LESLY R, SCHUBERT D: Hydrogen peroxide mediates amyloid β protein toxicity. Cell 1994; 77: 817-827
10. YAMADA K, TANAKA T, HAN D, SENZAKI K, KAMEYAMA T, NABESHIMA T: Protective effects of idebenone and α-tocopherol on b-amyloid-(1-42) induced learning and memory deficits in rats: implication of oxidative stresse in β-amyloid-induced neurotoxicity in vivo. Eur J Neurosci 1999; 11: 83-90
11. SANO M, ERNESTO C, THOMAS RG, KLAUBER MR, SCHAFER K, GRUNDMAN M, WOODBURY P, GROWDON J, COTMAN DW, PFEIFFER E, SCHNEIDER LS, THAL LJ: A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimers disease. N Engl J Med 1997; 336: 1216-1222
12. MASAKI KH, LOSONCZY KG, IZMIRLIAN G, FOLEY DJ, ROSS GW, PETROVITCH H, HAVLIK R, WHITE LR: Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 2000; 54: 1265-1272
13. KÁRPÁTI E, SZPORNY L: General and cerebral haemodynamic activity of ethyl apovincaminate. Arzneimittelforsch 1976; 26: 1908-1912
14. OTOMO E, ATARASHI J, ARAKI G, ITO E, OMAL T, KUZUYA F, NUKADA T, EBI O: Comparison of vinpocetine with ifenprodil and dihydroergotoxine mesylate treatment and results of long treatment with vinpocetine. Curr Ther Res 1985; 37: 811-821
15. KING GA: Protective effects of vinpocetine and structurally related drugs on the lethal consequences of hypoxia in mice. Arch Int Pharmacodyn 1987; 286: 299-307
16. SAUER D, RISCHKE R, BECK T, ROSSBERG C, MENNEL HD, BIELENBERG GW, KRIEGLSTEIN J: Vinpocetine prevents ischemic cell damage in rat hippocampus. Life Sci 1988; 43: 1733-1739
17. ARAKI T, KOGURE K, NISHIAKA K: Comparative neuroprotective effect of pentobarbital, vinpocetine, flunarizine and ifenprodil on ischemic neuronal damage in the gerbil hippocampus. Res Exp Med 1990; 190: 19-23
18. RISCHKE R., KRIEGLSTEIN J: Effects of vinpocetine on local cerebral blood flow and glucose utilization seven days after forebrain ischemia in the rat. Pharmacology 1990; 41: 153-160
19. KISS B, KÁRPÁTI E: Mechanism of action of vinpocetine. Acta Pharm Hung 1996; 66: 213-224
20. ERDÖ SL, NING-SHENG C, WOLFF JR, KISS B: Vinpocetin protects against excitotoxic cell death in primary cultures of rat cerebral cortex. Eur J Pharmacol 1990; 187: 551-553
21. MIYAMOTO M, MURPHY TH, SCHNAAR RL, COYLE JT: Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J Pharmacol Exp Ther 1989, 250: 1132-1140
22. SCHMIDT J: Comparative studies on the anticonvulsant effectiveness of nootropic drugs in kindled rats. Biomed Biochim Acta 1990; 49: 413-419
23. LAKICS V, SEBESTYÉN MG, ERDÖ SL: Vinpocetine is a highly potent neuroprotectant against veratridine-induced cell death in primary cultures of rat cerebral cortex Neurosci Lett 1995; 185:127-130
24. i rise in synaptosomes. NeuroReport 1998; 9: 1849-1853
25. 2+ channels: effects of bifemelane and several nootropic agents. Eur J Pharmacol 1990; 189:51-58
26. 3H]MK-801 binding. Eur J Pharmacol 1991; 207: 119-128
27. KISS B, CAI NS, ERDÖ SL: Vinpocetine preferentially antagonises quisqualate/AMPA receptor responses: evidence from release and ligand binding studies. Eur J Pharmacol 1991; 209: 109-112
28. KRIEGLSTEIN J, RISCHKE R: Vinpocetine increases the neuroprotective effect of adenosine in vitro. Eur J Pharmacol 1991; 205: 7-10
29. OLÁH VA, BALLA G, BALLA J, SZABOLCS A, KARMAZSIN L: An in vitro study of the hydroxyl scavenger effect of Cavinton. Acta Paediatr Hung 1990; 30: 309-316
30. ORVISKÝ E, SOLTES L, STANCIKOVA M. High-molecular-weight hyaluronan- a valuable tool in testing the antioxidative activity of amphiphilic drugs stobadine and vinpocetine. Pharm Biomed Anal 1997; 16: 419-424
31. TSUYUKI UY, OKUYAMA S, ARAKI H: VA-045, a novel apovincamic acid derivative attenuates neuronal injury induced by hypoxia or by excitatory amino acids in cultures of rat cortices. Life Sci 1996; 59: 1571-1578
32. SANTOS MS, DUAARTE AI, MOREIRA PI, OLIVEIRA CR: Synaptosomal response to oxidative stresse: effect of vinpocetine. Free Rad Res 2000; 32: 57-66
33. PEREIRA C, AGOSTINHO P, OLIVEIRA CR: Vinpocetine attenuates the metabolic dysfunction induced by amyloid β-peptides in PC12 cells. Free Rad. Res 2000; 33: 497-506
34. 2+ uptake in synaptosomes. Brain Res. 1993; 609: 117-123
35. CARDOSO SM, PEREIRA C, OLIVEIRA CR: The protective effect of vitamin E, idebenone and reduced glutathione on free radical mediated injury in rat brain synaptosomes. Biochem Biophys Res Commun 1998; 246: 703-710
36. HALLIWELL B, GUTTERIDGE JMC: Oxygen radicals and the nervous system. Trends Neurosci 1985; 8: 22-26
37. GUTTERIDGE JMC, HALLIWELL B: The measurements and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 1990; 15: 129-135
38. WITTING LA: Vitamin E and lipid antioxidants in free-radical initiated reaction. Free Radical in Biology, (W. A. Pryor, Ed), 1980; pp. 295-319, Academic Press, New York
39. AGOSTINHO P, DUARTE CB, OLIVEIRA CR: Impairment of excitatory amino acid transporter activity by oxidative stresse conditions in retinal cells: effect of antioxidants. FASEB J 1997; 11: 154-163
40. REGO AC, SANTOS MS, PROENÇA MT, OLIVEIRA CR: Influence of vitamin E on retinal cell survival. Toxicology 1998; 128: 113-124
41. CARDOSO SM, PEREIRA C, OLIVEIRA CR: Mitochondrial function is differentially affected upon oxidative stresse. Free Radic Biol Med 1999; 26: 3-13
42. + concentration increases in cultured retinal cells under oxidative stresse conditions. Neurosci Res 1996; 25: 343-351
43. ROMANO C, PRICE MT, OLNEY JW: Delayed excitotoxic neurodegeneration induced by excitatory amino acid agonists in isolated retina. J Neurochem 1995; 65: 59-67
44. + channels in rat cortical neurons. Eur J Pharmacol 1995; 273: 303-306
45. PELLEGRINI-GIAMPIETRO D, CHERICI G, ALESIANI M, CARLA V, MORONI F: Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. J Neurosci 1990; 10: 1035-1041
46. GLOBUS O, ALONSO WD, DIETRICH WD, BUSTO R, GINSBERG MD: Glutamate release and free radical production following brain injury: effects of post traumatic hypothermia. J Neurochem 1995; 65: 1704-1711
47. LANCELOT E, CALLEBERT J, REVAUD M. L, BOULU RG, PLOTKINE M: Detection of hydroxyl radicals in rat striatum during transient focal cerebral ischemia: possible implication in tissue damage. Neurosci Lett 1995; 197: 85-88
48. SUNO M, NAGAOKA A: Inhibition of lipid peroxidation by a novel compound (CV-2619) in brain mitochondria and mode of action of inhibition. Biochem Biophys Res Commun 1984; 125: 1046-1052
49. RUDOLPHI KA, SCHUBERT P, PARKINSON FE, FREDHOLM BB: Neuroprotective role of adenosine in ischemia. Trends Pharmacol Sci 1992; 13: 439-445.
50. BEHL C, DAVIS J, COLE GM, SCHUBERT D: Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem Biophys Res Commun 1992; 186: 944-950
51. BEHL C, TRAPP T, SKUTELLA T, HOLSBOER F: Protection against oxidative stresse-induced neuronal cell death-a novel role for RU486. Eur J Neurosci 1997a; 9: 912-920
52. BEHL C, SKUTELLA T, LEZOUALC'H F, POST A, WIDMANN M, NEWTON C, HOLSBOER F: Neuroprotection against oxidative stresse by estrogens: structure-activity relationship. Mol Pharmacol 1997b; 51: 535-541
53. PEREIRA C, SANTOS MS, OLIVEIRA C: Involvement of oxidative stresse on the impairment of energy metabolism induced by Aβ-peptides on PC12 cells. Protection by antioxidants. Neurobiol Dis 1999; 6: 209-219
54. PEREIRA C, GRAZINA MM, OLIVEIRA C, β-Amyloid protein impairs mitochondrial function Em: Mitochondrial ubiquinone (coenzyme Q10): biochemical, functional, medical and therapeutic aspects in human health and diseases. (Eds. Ebadi, M.; Marwah, J. e Chopra, R. K.) 2001; vol. 2: 282-300
55. PEREIRA C, SANTOS MS, OLIVEIRA C: Mitochondrial function impairment induced by amyloid β-peptide on PC12 cells. NeuroReport 1998; 9: 1749-1755
56. BUTTERFIELD DA, HENSLEY K, HARRIS M, MATTSON, MP, CARNEY J: β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem Biophys Res Commun 1994; 200: 710-715
57. HENSLEY K, CARNEY JM, MATTSON MP, AKSENOVA M, HARRIS M, WU JF, FOYD R, BUTTERFIELD DA: A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc Natl Acad Sci USA 1994; 91: 3270-3274
58. PAPPOLLA MA, SOS M, OMAR RA, BICK RJ, HICKSONBICK DLM, REITER RJ, EFTHIMIOPOULOS S, ROBAKIS NK: Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J Neurosci 1997; 17: 1683-1690
59. SHIBOTA M, KAKIHANA M, NAGAOKA A: The effect of vinpocetine on the brain glucose uptake in mice. Folia pharmacol Jap 1982; 80: 221-224
60. 2+ channel blockers attenuate β-amyloid peptide toxicity to cortical neurons in culture. J Neurochem 1994; 62: 372-375
61. 2+ channels: a possible involvement of free radicals. J Neurochem 1997; 68: 265-271
62. MATTSON MP, CHENG B, DAVIS D, BRYANT K, LIEBERBURG I, RYDEL RE: β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 1992; 12: 379-389
63. MATTSON MP, TOMASELLI K, RYDEL RE: Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res 1993; 621: 35-49
64. GOODMAN Y, STEINER MR, STEINER SM, MATTSON MP: Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res 1994; 654: 171-176
65. FUKUYAMA R, WADHWANI KC, GALDZICKI Z, RAPOPORT SI, EHRENSTEIN G: β-Amyloid polypeptide increases calcium-uptake in PC12 cells: a possible mechanism for its cellular toxicity in Alzheimer's disease. Brain Res 1994; 667: 269-272
66. YALLAMPALLI S, MICCI M-A, TAGLIALATELA G: Ascorbic acid prevents β-amyloid-induced intracellular calcium increase and cell death in PC12 cells. Neurosci Lett 1998; 251: 105-108
67. THAL LJ, SALMON DP, LASKER B, BOWER D, KLAUBER MR: The safety and lack of efficiency of vinpocetine in Alzheimer's disease. J Am Geriatr Soc 1989; 37: 515-520
68. TANG Y-P, NODA Y, HASEGAWA T, NABESHIMA T: Effects of VA-045 on learning and memory deficits in traumatic brain injury (TBI)-induced retrograde and anterograde amnesic mice. Brit J Pharmacol 1997; 122: 257-264